Biologically, knockdown of UBE2F or SAG suppresses growth, cell cycle progression, reduced cell size, and induces autophagy in in vitro liver cancer cell culture models, whereas Ube2f liver specific deletion inhibits steatosis and tumorigenesis in an in vivo liver cancer model triggered by Pten loss. The gene discussed is SAG; the disease is liver cancer.